Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"DNA/various proteins" refers to the complex and dynamic association of deoxyribonucleic acid (DNA) with structural and regulatory proteins, such as histones, polymerases, and topoisomerases, which are collectively known as chromatin [2][11]. This target is the primary focus of many traditional cytotoxic chemotherapy agents that lack a single specific protein target but instead disrupt the integrity and function of the entire nucleoprotein assembly [3][6]. Drugs interacting with this target often utilize mechanisms such as alkylation, intercalation, or the creation of DNA-protein crosslinks to interfere with DNA replication, transcription, and repair [1][3]. While effective at inducing apoptosis in rapidly dividing cancer cells, the relative lack of specificity results in significant safety concerns, including myelosuppression and the potential for secondary malignancies [6][12]. Modern therapeutic research continues to refine this target by focusing on specific protein-DNA interactions, such as those involving DNA repair enzymes or epigenetic modifiers, to improve efficacy and reduce systemic toxicity [1][5].
Drugs targeting this complex act via several mechanisms, including DNA alkylation, intercalation, the formation of DNA-protein crosslinks, and the inhibition of enzymes such as topoisomerases and polymerases which are essential for DNA processing [3][6][12].
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Deoxyribonucleic acid and associated proteins.